- Messages
- 1,840
Diabetes UK have published a document based on the experience of UK centres looking after Covid-19 patients with diabetes:- https://www.diabetes.org.uk/resources-s3/public/2020-04/COvID_Front_Door_v1.0.pdf
In it, they say:-
Medscape also have an article discussing hyperglycaemia and DKA in hospital patients with Covid-19, based on experiences in the USA:- https://www.medscape.com/viewarticl...422_mscpedit&uac=313372PR&impID=2355472&faf=1
In it, they say:-
COVID-19 infection in people with or without previously recognised diabetes increases the risk of the EMERGENCY states of hyperglycaemia with ketones, Diabetic KetoAcidosis (DKA) and Hyperosmolar Hyperglycaemic State (HHS)COVID-19 infection in people with or without previously recognised diabetes increases the risk of the EMERGENCY states of hyperglycaemia with ketones, Diabetic KetoAcidosis (DKA) and Hyperosmolar Hyperglycaemic State (HHS).
Being acutely unwell with suspected/confirmed COVID-19 requires adjustment to standard approaches to diabetes management.
They then go on to discuss the management of diabetes whilst in hospital. Interestingly, they recommend that SGLT-2 inhibitors (glifozins) are discontinued on admission to hospital.Being acutely unwell with suspected/confirmed COVID-19 requires adjustment to standard approaches to diabetes management.
Medscape also have an article discussing hyperglycaemia and DKA in hospital patients with Covid-19, based on experiences in the USA:- https://www.medscape.com/viewarticl...422_mscpedit&uac=313372PR&impID=2355472&faf=1
